Treatt appoints SkinBioTherapeutics' Manprit Randhawa as interim CFO

Related news

Treatt PLC on Friday said it has appointed Manprit Randhawa as interim chief financial officer, effective from Monday.

The Suffolk, England-based extracts and ingredients manufacturer confirmed that as previously announced Ryan Govender will step down as director and CFO at the end of September, after completing a handover period to Randhawa.

Treatt said Randhawa will support the company while the process to appoint a permanent replacement continues.

Randhawa will join Treatt’s executive committee but will not be a member of the board. He is joining Treatt from life science firm SkinBioTherapeutics, where he was CFO.

‘We are delighted to welcome Manprit as Interim Chief Financial Officer. He brings a wealth of strategic and commercial expertise to Treatt, and we look forward to working with him,’ said Treatt Chair Vijay Thakrar.

Shares in Treatt were up 0.1% at 228.66 pence in London on Friday morning.

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Directors

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.